The human arterial blood pressure shows not only exogenic alterations, but
also spontaneous fluctuations. This blood pressure variability has both sci
entific and clinical relevance. A well-known phenomenon is the so-called "w
hite coat hypertension" which may severely affect diagnosis and therapy of
essential hypertension. Furthermore, several studies have provided evidence
that die degree of end-organ damage in hypertensive patients is closely re
lated to the circadianblood pressure variability. Therefore, it is tempting
to suggest that an optimal antihypertensive treatment should take an impro
vement of the blood pressure variability into consideration.
Among other mechanisms modulating the arterial blood pressure, the barorefl
ex function has to be mentioned. Diseases like chronic renal failure, treat
; ment with drugs like ciclosporine A and also smoking have been shown to r
educe the baroreflex sensitivity.
As the baroreflex sensitivity mainly reflects interactions between the bloo
d pressure variability on the one hand and the heart rate variability on th
e other hand, it is not surprising that also a reduced baroreflex function
is an independent cardiovascular risk factor.